https://nova.newcastle.edu.au/vital/access/manager/Index ${session.getAttribute("locale")} 5 Continuous versus intermittent extended adjuvant letrozole for breast cancer: final results of randomized phase III SOLE (Study of Letrozole Extension) and SOLE Estrogen Substudy https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:53186 Wed 07 Feb 2024 15:28:37 AEDT ]]> Quality of life and quality-adjusted survival (Q-TWiST) in patients receiving dose-intensive or standard dose chemotherapy for high-risk primary breast cancer https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:5531 Sat 24 Mar 2018 07:46:41 AEDT ]]>